PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of cermJournalThis ArticleAboutFor Contributorse-Submission
 
Clin Exp Reprod Med. 2012 September; 39(3): 95–106.
Published online 2012 September 30. doi:  10.5653/cerm.2012.39.3.95
PMCID: PMC3479238

Regulation and 3 dimensional culture of tertiary follicle growth

Abstract

It has been revealed that multiple cohorts of tertiary follicles develop during some animal estrous cycle and the human menstrual cycle. To reach developmental competence, oocytes need the support of somatic cells. During embryogenesis, the primordial germ cells appear, travel to the gonadal rudiments, and form follicles. The female germ cells develop within the somatic cells of the ovary, granulosa cells, and theca cells. How the oocyte and follicle cells support each other has been seriously studied. The latest technologies in genes and proteins and genetic engineering have allowed us to collect a great deal of information about folliculogenesis. For example, a few web pages (http://www.ncbi.nlm.nih.gov; http://mrg.genetics.washington.edu) provide access to databases of genomes, sequences of transcriptomes, and various tools for analyzing and discovering genes important in ovarian development. Formation of the antrum (tertiary follicle) is the final phase of folliculogenesis and the transition from intraovarian to extraovian regulation. This final step coordinates with the hypothalamic-pituitary-ovarian axis. On the other hand, currently, follicle physiology is under intense investigation, as little is known about how to overcome women's ovarian problems or how to develop competent oocytes from in vitro follicle culture or transplantation. In this review, some of the known roles of hormones and some of the genes involved in tertiary follicle growth and the general characteristics of tertiary follicles are summarized. In addition, in vitro culture of tertiary follicles is also discussed as a study model and an assisted reproductive technology model.

Keywords: Tertiary follicle, Growth, Folliculogenesis, In vitro follicle culture

Introduction

Folliculogenesis is the process by which the female germ cell develops within the somatic cells of the ovary and matures into a fertilizable oocyte (Figure 1A) [1]. Newborn mouse ovaries are densely packed with oocytes called naked oocytes (germ cell cysts, clusters, nests, or syncytia) [2,3], most of which are present in clusters with no evidence of surrounding granulosa cells [2]. The oocytes in the cluster are connected by intercellular bridges (Figure 1B). Most of the oocytes enter meiosis during embryonic life, and at birth, some oocytes are in the transitory stages of prophase I. Folliculogenesis is initiated by coupling between the primary oocyte and ovarian stromal cells. One to 2 days after birth, a number of oocytes are surrounded by flat squamous pre-granulosa cells (primordial follicle) (Figure 1C). By postnatal day 3, the pre-granulosa cells differentiate to granulosa cells and the oocyte reaches growth beyond 20 µm. At postnatal day 7, most of the germ cell cysts have disappeared and primordial follicles are the most abundant follicular type, but primary and secondary follicles are present in the medullary region (Figure 1D, E). By postnatal day 21, early antral (early tertiary) follicles are observed and the size of oocytes reaches its final diameter. In contrast, in humans, primordial follicles are formed during gestation. Primordial follicles are observed after 20 weeks of gestation, and preantral (secondary) and antral (tertiary) follicles are observed from 26 weeks onwards (Figure 1F, G). In newborn human females, approximately 400,000 follicles remain. Follicular maturation and atresia occur prenatally and throughout childhood [4,5]. During folliculogenesis, follicles have to be recruited and selected to participate in ovulation. "Recruitment" of follicles can have several meanings, but here it refers to the emergence of a cohort of medium-size follicles. "Selection" refers to the preferential growth of the dominant follicle from the cohort of recruited tertiary follicles.

Figure 1
Photomicroscopy of mouse follicles for follicle classification. Sections of whole ovary (A, ×40), germ cell cyst (B, ×400), primordial follicle (C, ×400), primary follicle (D, ×400), secondary follicle (E, ×400), ...

Multiply recruited follicles develop during the estrous cycle of several animal species and the menstrual cycle of humans. Recruited follicle develops an antrum between the granulosa cells [6]. Tertiary follicle formation is associated with continued proliferation of granulosa and theca cells, further increased thecal vascularization, and further oocyte enlargement. By the transition from secondary to tertiary follicles, the ovary can clearly works as an endocrine organ. Finally, the grown tertiary follicles release matured oocytes. Development and differentiation of tertiary stage follicles is important in selection of dominant follicles, choosing competent oocytes, preserving fertility, and helping fertilization. These processes are under the control of the hypothalamic-pituitary-ovary axis and the local regulation including hormones and cytokines. Using knockout mice, the critical genes that are important in tertiary follicle growth and functional regulation have now been identified. However, they are very complex, so they are not fully understood and so cannot yet be applied to assisted reproduction. For example, the mechanisms of the explosive growth of tertiary follicles have not been fully elucidated. In vitro culture of follicles can help in exploring the role of various candidate genes and chemicals in folliculogenesis. Using an in vitro culture system, we can now obtain competent oocytes from follicles or oocyte-cumulus complexes involved in producing a new generation, although the yield is low. Therefore, much more efficient in vitro culture technology is needed to improve the quality of oocytes and our understanding of their mechanisms.

General characteristics of tertiary follicles

Recruited late secondary follicles cannot form tertiary follicles without sufficient gonadotropin stimulation. Gonadotropins trigger the antral formation, the expression of related genes, and the selection of the dominant follicles. In the early tertiary stage follicles, the oocyte grows to the final diameter of approximately 70 µm and is surrounded by multiple layers of granulosa cells that contain scattered areas of interstitial fluid (Figure 1F). These scattered areas of fluid coalesce to form the antral cavity (Figure 1G) [7].

Gonadotropins trigger the expression of downstream genes and the downstream genes regulate the growth and differentiation of follicle cells. FSH is survival factor of early tertiary follicles; without FSH, these follicles undergo apoptosis [8]. In the dominant follicles, LH stimulates theca cell androgen production, while FSH stimulates granulosa cell proliferation, aromatization of androgens to estrogen, and LH receptor expression [9]. Inhibin and activin, secreted by granulosa cells are involved in the feedback regulation of FSH secretion [10]. Thereby, tertiary stage follicles participate actively in the hypothalamic-pituitary-ovarian axis.

The structural connection between oocyte and granulosa cells is critical for antrum formation and oocyte competency. An oocyte builds its own microenvironment in the follicle and controls the differentiation of the follicle cells and its own. Microtubule transzonal projections (TZPs) mediate the structural formation of TZPs between the oocytes and granulosa cells [11]. After selection by the complicated web of interactions among the oocyte, granulosa cells, and theca cells, an FSH and LH surge triggers the release of oocytes.

The growth of tertiary follicles has a well-characterized pattern of growth and development. Growth of tertiary follicles includes expansion of the antrum and the increase in the number of follicle cells. It is known that granulosa and theca cells continue to undergo mitosis concomitant with an increase in antrum volume. On the other hand, as follicle enlarge, the granulosa cells and theca cells progressively stop dividing to express differentiated functions. Differentiation of theca and granulosa cells is under the control of FSH, LH, prolactin, and local regulators, which can be paracrine or autocrine. This is observed when the follicle diameter reaches a specific size, such as 6 mm in humans. The increase in the ability of theca cells to produce androgen coincides with the increase in the ability of granulosa cells to aromatize them into estrogen. Angiogenic factors are also important in tertiary follicular growth, particularly the selective growth of oocytes and follicles. Epidermal growth factor and GAGs are included in angiogenic activity [12].

During the tertiary follicle stage, to support the fertility of the ovulated oocyte, the oocyte is protected in various ways during follicular extrusion and is assisted in sperm binding and preparation for fertilization. Hyaluronic acid (HA), prostaglandin E2, pentraxin 3, and tumor necrosis factor alpha induced protein 6 (Tnfaip6) are involved in these processes [13]. Tnfaip6-/- mice lack hyaluronan and heavy chain inter-α-trypsin inhibitor family complexes [14]. In the ovulated oocytes of Ptx3 knockout mice, the cumulus cells are missing [13].

Role of hormones in the growth of tertiary follicles

The growth of tertiary follicles is controlled both at the system and local levels. In system level control, the hypothalamus-pituitary-ovarian axis is known to be the main regulator. FSH is the main regulator of recruiting the secondary follicles to grow to tertiary follicles. The actions of FSH are modulated at the system level by tissue receptivity (number and affinity of receptors) and by local regulators (steroids and proteins) that increase or decrease the follicular response to gonadotropins. FSH triggers gene expression which is involved in antral formation, in preparing for ovulation, and in oocyte competency [15]. It is cleared from FSH beta (Fshb) knockout mice. In Fshb knockout mice, follicles arrest at the late secondary follicle (preantral) stages [16,17]. Complete restoration of folliculogenesis in Fshb null mice is accomplished by the expression of FSH [18]. FSH receptor (Fshr) null mice have changes in oocyte-granulosa cell communication [19]. In these mice, reduced oocyte growth is observed and the protein levels of KIT, epithelial growth factor kit ligand (KITL), and bone morphogenic protein 15 (BMP-15) are decreased [19]. Serum/glucocorticoid inducible kinase, Cypll1, and aromatase (CYP19) are down-regulated significantly in the ovaries of Fshr null mice [20]. Arresting of tertiary follicle development in insulin-like growth factor 1 (Igf1) null female mice is caused by a low expression levels of FSHR [21,22].

In women with mutant in Fshb, primary amenorrhea, absent breast development, low FSH, high LH, and undetectable estrogen are detected. The observed phenotype in women with the Fshb mutations mimics well the mouse Fshb gene mutation [23]. In the case of mutations in the Fsh gene, follicles develop to the secondary stage as in Fshr null mice [24].

LH is critically involved in tertiary follicle growth and maturation. Basal levels of LH are important for recruiting of secondary follicles to grow to become tertiary follicles [25]. LH stimulates androgen production in theca cells. These androgens are transformed into estrogen through the action of the aromatase system [26]. LH beta (Lhb) null female mice are infertile. Primary and secondary follicles with intact theca cell layers develop but healthy large tertiary follicles are absent. However, in LH receptor (Lhcgr) knockouts, late secondary and tertiary follicles are present. As compared with Fshr knockouts, Lhcgr knockouts have more advanced follicular structures [27,28].

Estrogen is synthesized in the granulosa cells of developing follicles. It stimulates granulosa cell growth, increases the synthesis of IGF1, maintains FSHR, induces LH receptor expression, augments aromatase activity and subsequent estrogen production, and attenuates granulosa cell apoptosis. Estrogen stimulates the transition from the secondary to tertiary stage of folliculogenesis and alters the ratio of follicular parenchyma to ovarian stroma in favor of stroma [29]. Estrogen receptor beta (Esr2) is expressed at a higher level in the granulosa cells of tertiary follicles than in estrogen receptor alpha (Esr1) is expressed in theca cells and interstitial cells [30, 31]. Using Esr1, Esr2, and aromatase knockout mouse models, estrogen appears to play an important role in the feedback regulation of ovulation and continued follicle growth but does not interfere with oocyte growth [31-33]. A woman who has a mutation in the cytochrome P450 (Cyp19a1, P450 aromatase) will have primary amenorrhea and cystic ovaries [34,35].

Growth hormone receptor (Ghr) RNA is localized in the granulosa cells of tertiary follicles [36]. IGF1 does not restore the ovulation rate in GH receptor knockout mice. In Ghr knockouts, the number of apoptotic follicles is increased [37].

Leptin is expressed in oocytes, granulosa cells, and theca cells. It increases the meiotic resumption in fully grown follicle-enclosed oocytes [38]. Leptin is highly expressed in the theca cells of antral follicles. Although leptin is expressed in the oocytes and follicle cells, it is thought that non-gonadal leptin can restore fertility [39]. Fertility of ob/ob mice can be restored by replacement of leptin or gonadotropins [39]. Leptin can suppress ovarian steroid synthesis and IGF1 synergistic effects with FSH on estrogen production in granulosa cells and also inhibits aromatase activity [40,41]. It has also been suggested that leptin-induced angiogenesis may be important in folliculogenesis [42].

Activins (isoforms: A [βA homodimer], AB [βA βB heterodimer], and B [βB homodimer]) and inhibins (isoforms: A [α and βA heterodimer] and B [α and βB heterodimer]) are synthesized in ovarian follicles, the pituitary gland, placenta, and other organs. Inhibin and activin have almost directly opposite biological effects. In the ovaries, activin is synthesized in the granulosa cells of tertiary follicles and is involved in the negative feedback loop of FSH. Activin supports FSH secretion in the pituitary and is involved in the cyclic recruitment of follicles. Activin A inhibits spontaneous luteinization in mature tertiary follicles through the inhibition of LH-induced production of progesterone and oxytocin in granulosa cells [43]. It also attenuates LH-dependent androgen production in theca cells [44]. The major activin signaling receptor is activin receptor type IIa (Acvr2a). Acvr2a null mice have a few tertiary follicles and follicular atresia and rare corpora lutea [45]. The effect of activin is under the control of follistatin.

In the ovaries, inhibin is synthesized in the granulosa cells of tertiary follicles and is involved in the negative feedback loop of FSH. It is suggested that inhibin is needed in late stage folliculogenesis in mice. Inhibin α (Inha) null mice develop ovarian tumors [10]. If the ovaries from the inhibin α null mice are transplanted to an immunocompatible host prior to gross tumor development, the ovaries have few follicles beyond the preantral stage. Furthermore, from the superovulation induced in these mice, the ovulated number of oocytes is much lower compared to controls [46]. Inhibin A synthesis increases in the granulosa cells of selected tertiary follicles and enhances LH-induced androgen production [47]. In this way, granulosa cells are able to maintain a sufficient supply of thecal androgen required for their greatly increased estrogen synthesis during the pre-ovulatory phase [48].

Local levels of inhibin and activin change according to the stage of folliculogenesis. It has been proposed that an orderly transition from an inhibin B/activin follicular environment to an inhibin A/follistatin environment is critical for dominant follicle development in women [49]. As follicles reach the size at which the FSH-dependent follicle selection mechanism operates, these follicles produce more activin relative to inhibin, while larger selected follicles secrete proportionally more inhibin [50,51]. A changing intrafollicular balance between inhibin and activin contributes to granulosa cell proliferation and differentiation, androgen synthesis in theca cells, and oocyte support and development. Interestingly, inhibin A, or its free α-subunit has a negative effect on both oocyte maturation and developmental competence. In contrast, activin A accelerated oocyte maturation [52,53] and developmental competence [54].

Antimullerian hormone (AMH) is synthesized in the granulosa cells of secondary and early tertiary follicles. The levels of intrafollicular AMH gradually decrease during tertiary follicle growth until selection time. Its expression is under the control of FSH and estrogen. AMH reduces the FSH responsiveness of small tertiary follicles [55].

Important genes in the growth of tertiary follicles

It is well known that growth factors originate from follicle cells and oocytes play an important role in control of tertiary follicles such as follicle cell proliferation, apoptosis, release of hormones, and response to upstream hormonal responses [56]. A few kinds of growth factors in null mice have shown follicles arrested at the secondary or tertiary stages. Igf1 and its receptor is expressed in granulosa cells of growing follicles and increases during antral follicle growth. Igf1 knockout mice do not contain tertiary follicles and cannot ovulate [21,57]. Forkhead/winged helix transcription factor (Foxc1) is one of the transforming growth factor beta1 (TGF-β1)-responsive gene in the ovarian cell line [58]. The transplanted ovaries of Foxc1 null mice have no follicles developed beyond the early tertiary follicle, because theca and granulosa cell layers are disrupted [59]. In cyclin D2 null female mice, arresting of tertiary follicle development is observed at the same secondary follicle stages as Fshb null ovaries [16]. In connexin 43 (Gja1) null mice, late tertiary follicles are not observed [60-62].

Some factors are involved in the interconnection between hormones and local communicators during growth of tertiary follicles. BMPs that are expressed in the granulosa cells of tertiary follicles promote the proliferation and FSH-dependent function of granulosa cells. Those include BMP-2, -5, and -6. These facilitate follicle survival and the prevention of premature luteinization and/or atresia [63,64]. BMP-2 promotes estrogen and inhibin secretion from granulosa cells [65]. In addition these BMPs have a paracrine role in theca cells and attenuate LH-dependent androgen production in small- to medium-sized tertiary follicles. BMP-5 reduces FSH-stimulated progesterone production. BMP-6 derived from granulosa cells down-regulates adenylate cyclase activity and attenuates FSH action on granulosa cells [66]. At the time of dominant follicle selection, the dramatic loss of BMP-6 mRNA levels has been noted [67]. BMP-6 inhibits gonadotropin-stimulated progesterone secretion but has no effect on P450arom expression of estrogen secretion [66]. It enhances basal and IGF-stimulated estrogen, inhibin A, activin A, follistatin secretion, and cell number [66].

BMPs that are expressed in the theca cells of tertiary follicles promote granulosa cell proliferation and improve follicle survival and prevention of premature luteinization and/or atresia. They include BMP-2, -3b, BMP-4, and -7 [48,64,66]. BMP-2 promotes estrogen and inhibin secretion from granulosa cells [65]. BMP-4 attenuates FSH-stimulated progesterone concomitant with a decrease in steroidogenic acute regulatory (StAR) and P450scc, but enhances FSH-stimulated estrogen, inhibin A, activin A, and follistatin secretion, without affecting cell proliferation [66,68,69]. BMP-4 also suppresses basal and LH-induced androgen secretion and enhanced cell proliferation in theca cells [66]. BMP-7 performs autocrine and paracrine actions in tertiary follicles and enhances theca cell proliferation [66]. In granulosa cells, BMP-7 attenuates FSH-stimulated progesterone and enhances FSH-stimulated estrogen, inhibin A, activin A, and follistatin secretion, without affecting cell proliferation [66,68]. BMP-7 suppresses basal and LH-induced androgen secretion.

The biological function of BMPs is antagonized by BMP-binding proteins such as follistatin, noggin, chordin, gremlin, NBL1, and BMP and activin membrane-bound inhibitor (BAMBI). These BMP-binding proteins express in tertiary follicles and block BMP action. Follistatin can bind BMP-4, -6, and -7 and inhibit their effects on granulosa cells although evidently not on theca cells [66]. It can prevent the inhibitory actions of BMP-15 on FSH receptor expression [66]. Noggin neutralizes BMP-2 and BMP-4 action on granulosa cells [70]. Gremlin suppresses BMP-4 signaling in granulosa cells [71]. The NBL1 gradient is established by oocyte-derived growth/differentiation factor 9 (GDF-9), and its gradient serves as an antagonist barrier that spatio-temporally modulates the actions of theca-derived BMP-4 and granulosa/theca derived BMP-2 during folliculogenesis.

TGF-β is expressed in both theca and granulosa cells during tertiary follicle development [72]. TGF-β receptor is distributed ubiquitously in most cell types. TGF-β stimulates FSH receptor expression [73], and amplifies FSH-induced aromatase activity, inhibin production, progesterone production, and LH receptor induction [74].

A few genes are known to be involved in the control of steroid hormone biosynthesis during the growth of tertiary follicles. TGF-β suppresses theca P450c17 expression and androgen production [75]. Hepatocyte growth factor (HGF) is derived mainly from theca and interstitial cells in tertiary follicles. HGF mediates steroidogenesis and suppresses the apoptosis of tertiary follicles. It induces granulosa cell proliferation [76].

Proliferation or apoptosis regulating genes have also been identified during tertiary follicle growth. Cyclin D2 promotes granulosa cell proliferation [22,77,78]. Extracellular-regulated protein kinases 1 and 2 mediate a decrease in granulosa cell proliferation [79]. Hoxa7 (one of the homeobox genes) is expressed in granulosa cells and is stimulated by GDF-9. It regulates granulosa cell proliferation [80]. Tumor necrosis factor-alpha (TNFα) is produced by cumulus cells and is involved in preventing fragmentation of oocytes [81]. Nodal is involved in promoting follicular atresia [82]. NAIP is expressed in granulosa cells and protects ovarian follicular cells from apoptosis [83].

Keratinocyte growth factor (KGF) (i.e., fibroblast growth factor-7) and the epithelial growth factor KITL interact to coordinate the growth of later-stage tertiary follicles [84]. A local feedback loop is built between theca cells and granulosa cells by these ligands. Theca cell-derived KGF and HGF stimulate granulosa cell-derived KITL expression, and KITL, in turn, can stimulate theca cell-derived KGF and HGF expression. In addition, FSH directly stimulates KITL expression and LH stimulates KGF and HGF expression in theca cells [85].

Control of tertiary follicle growth by oocytes

It has been found that oocytes control the rate of follicular development [86]. When oocytes extracted from secondary follicles were reaggregated with somatic cells from newborns' ovaries, and transplanted into the renal capsules of bilaterally ovariectomized host females, tertiary follicles were visible in 9 days. As a control, primordial oocytes were rearranged with the same somatic cells and after 9 days, only secondary follicles were observed without tertiary follicles [86]. Within tertiary follicles, the oocytes continue to influence the behavior of the granulosa cells via the production of specific oocyte-secreted factors, hence regulating its own microenvironment [87,88]. As mentioned regarding the cellular communication between the oocyte and follicle cells, TZPs connect between oocytes and granulosa cells.

At least 5 growth factors are synthesized in the oocytes. These include GDF-9, BMP-6, BMP-15, FGF-8, and TGF-β2 [89]. GDF-9 is known as an oocyte-specific factor and modulator of TZP formation and controller of folliculogenesis. GDF-9 is essential in antral follicle growth [17,90]. Granulosa cells of tertiary follicles highly express some genes such as hyaluronan synthase (Has) Ptx3, Tnfaip6, and gremlin, by the treatment of GDF-9 [12,71]. GDF-9 inhibits urokinase plasminogen activator (Plau), and LH receptor mRNA. Gdf9 null mice clearly demonstrate the role of oocytes in granulosa cell proliferation and follicular progression [91]. GDF-9 promotes granulosa cell proliferation and provides premature luteinization and/or atresia. GDF-9 exerts its effect via regulation of gonadotropin action [92]. It suppresses FSH-stimulated progesterone and E2 production through suppression of P450arom activity [92,93] and attenuates FSH-induced LH receptor formation. GDF-9 also regulates cumulus expansion and expression of several key granulosa cell-specific genes such as Has2, cyclooxygenase 2 (Ptgs2), and Star protein mRNA synthesis. It also can induce progesterone production without FSH. However, it suppresses Plau and Lhcgr mRNA synthesis [94]. It has been shown that GDF-9 works with BMPs to maintain cell proliferation and provide premature luteinization and/or atresia.

BMP-6 and -15 derived from oocytes promote granulosa cell proliferation and improve follicle survival and prevention of premature luteinization and/or atresia [95]. BMP-6 expressed by oocytes down-regulates adenylate cyclase activity and attenuates FSH action on granulosa cells [63]. At the time of dominant follicle selection, a dramatic loss of Bmp-6 mRNA levels has been noted [89]. BMP-6 inhibits gonadotropin-stimulated progesterone secretion but has no effect on P450arom expression of estrogen secretion [63,96]. It enhances basal and IGF-stimulated estrogen, inhibin A, activin A, and follistatin secretion and cell number [97]. BMP-15 is required for follicle development to the ovulatory stage and is required for modulation of TZP formation [17]. BMP-15 attenuates FHS action on rat granulosa cells through suppression of FSH receptor expression [98] and inhibits gonadotropin-stimulated progesterone secretion [63,69]. In humans and sheep, BMP-15 enhances the proliferation of granulosa cells [99]. In the granulosa cells of early tertiary follicles, BMP-15 binds with the highest affinity to BMP receptor type-1B (BMPR1B), resulting in SMAD1/5/8 phosphorylation [100]. BMPR1B is expressed in oocytes and granulosa cells of tertiary follicles in mice [101].

Intermedin (IMD)/adrenomedullin 2 (ADM2) is synthesized in oocytes and is known to be a regulator of cell-cell communication in cumulus-oocyte-complexes. It suppresses cumulus cell apoptosis [102]. Communication between oocytes and granulosa cells and between follicle cells is pivotal in folliculogenesis. It is well known that the structural protein connexin is important in maintaining communication between oocytes and cumulus cells. Connexin 37 gap junctions develop between oocytes and granulosa cells. Connexin 37 is involved in the transition from secondary to tertiary follicle development [61]. Connexin 43 (Gja1) gap junctions also connect granulosa cells and oocytes. Connexin 43 null granulosa cells are unable to proliferate. Connexin 43 null mice contain developing preantral follicles, but late tertiary follicles are not observed and produce incompetent oocytes [60-62]. Oocytes recovered from Gja1 mutants could not be fertilized [103]. Connexin 43 expression is under the control of FSH and LH. FSH causes induction of connexin 43 synthesis but a preovulatory surge of LH is followed by a drop in the level of connexin 43 [104-106]. Its expression regulation by gonadotropins is mediated by steroid hormones, BMP/Smad, and the MAPK-Ras pathways [107,108].

Communication between oocytes and granulosa cells is the cause of establishment of the microenvironment for oocytes. By command of an oocyte-secreted morphogenic gradient, the tertiary follicle's granulosa cells begin to differentiate themselves into four distinct subtypes: the corona radiata that surround the zona pellucida, the membrana that is interior to the basal lamina, the periantral that is adjacent to the antrum, and the cumulus oophorus that connects the membrana and corona radiata granulosa cells together. Grondahl et al. [109] identified a total of 1,562 genes that are differentially expressed by >2-fold in the cumulus cells and mural granulosa cells, and demonstrated the specialized function of these cells.

In vitro tertiary follicle culture to obtain competent oocytes

In many fundamental studies the regulation mechanisms of tertiary follicle growth have been explored, but many issues, so far, remain unclear. One of the reasons is the complexity of in vivo regulation mechanisms and and their system. Dilution of the effect after treatment is the first error during in vivo study. From the study of Eppig and Schroeder [110], in vitro culture systems of follicles have been designed and examined. Eppig and Schroeder [110] were able to obtain living offspring from in vitro matured oocytes that were derived from preantral follicles. In 1996, Eppig and O'Brien [111] obtained better frequency of mature oocytes and mouse offspring using a two-step strategy. A few studies have shown successful folliculogenesis after growth on a biomatrix [112-114] and various culture devices [115,116]. Kreeger et al. [117] used an alginate-extracellular matrix gel scaffold containing defined extracellular matrix (ECM) compounds for the culture of follicles and then produced a steroid synthetic follicle culture system. However, they need a large number of pre-culture procedures and their production and testing capacity was too low. However, from their results it is suggested that the effects of ECM components in the scaffold depend upon both the components of the ECM and the initial culture stage of the follicles. The recently tested hyaluronan-based hydrogel scaffolding of follicles has limitations. The matrix mixed hydrogel scaffold also has limitations. Although the architecture of the follicles was maintained by hydrogel embedding, this did not increase the proportion of competent oocyte production [114].

On the other hand, tertiary stage folliculogenesis is critical in the maturity and competence of ovulated oocytes. Therefore, it is critical to understand the growth regulation and growth mechanisms of tertiary follicles. In addition it is critical to evaluate the relationship among gonadotropin, follicle cells, and grown oocytes. Progress toward developing a culture system that allows the complete growth of early tertiary follicles to rupture and oocyte maturation remains a major challenge. In one of our previous studies, we used the modified hanging-drop method with simple media, no antibiotics or scaffold, and gonadotropin-induced follicles. This method is simple compared to the methods using culture devices or scaffolds. Early tertiary follicles were isolated from the ovary with 27-G needles. Follicles were individually cultured for 39 hours at one follicle per well of a 96-well plate. The plates were inverted prior to incubation (Figure 2). The modified hanging-drop culture is as effective as the inverted culture of Nation and Selwood [115] for obtaining ovulated oocytes [118]. The growth of early tertiary follicles is improved by this method and the number of ovulated oocytes is also higher [118] (Figure 2). Based on this system, RNAi or other functional modulators were successfully and easily applied at cell or tissue levels [118]. Based on these studies, it is suggested that this modified hanging-drop culture method will be useful to study folliculogenesis in vitro and may be applied to assisted reproductive technology (ART). Although further optimization of the culture and scaffolding environment is necessary to obtain competent oocytes, in vitro culture technologies are opening new avenues toward assisted reproduction.

Figure 2
Modified hanging-drop culture of early tertiary follicles. (A) Light micrograph of tertiary follicle culture. An early tertiary follicle was dropped in one well of a 96-well tissue culture plate, and the plate was reversed and cultured. (B) Light micrograph ...

Conclusion

Although the development of tertiary follicles is necessary, it is not sufficient for fertilization. In the end, the grown follicles have to be selected to attend ovulation. It has been suggested that changes in intrafollicular activins, GDF-9, AMH, and several BMPs contribute to this selection process by modulating both FSH- and IGF-dependent signaling pathways in granulosa cells [119]. It is known that almost 90% of the initial pool is depleted by puberty in humans, and beyond age 37, the number of follicles approaches approximately 25,000 follicles and the rate of follicle loss increases so that by age 50, approximately 1,000 follicles remain [120,121]. Over the past two decades, numerous mouse models have been generated that demonstrate the importance of multiple signaling systems in follicle growth. Studies using mice provide a basis for understanding human infertility and disease as well as revealing new candidate genes for mutational analysis. However, it is not enough to evaluate the mechanisms of folliculogenesis. As a new approach, the in vitro follicle culture model is useful for exploring the phenomena in the growth and differentiation of follicles and preparation for the ovulation of oocytes and fertilization. Such approaches will accelerate resolution of the questions involved in folliculogenesis and in obtaining competent oocytes. By refining these skills, ART can be assisted to govern the regulators in insuring the maintenance of reproductive ability.

Footnotes

This work was supported by Sungshin Women's University.

No potential conflict of interest relevant to this article was reported.

References

1. Burns KH, Matzuk MM. The application of gene ablation and related technologies to the study of ovarian function. In: Leung PC, Adashi EY, editors. The ovary. 2nd ed. London: Elsevier; 2004. pp. 411–432.
2. Peters H. The development of the mouse ovary from birth to maturity. Acta Endocrinol (Copenh) 1969;62:98–116. [PubMed]
3. Pepling ME, Spradling AC. Mouse ovarian germ cell cysts undergo programmed breakdown to form primordial follicles. Dev Biol. 2001;234:339–351. [PubMed]
4. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17:121–155. [PubMed]
5. Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod. 2008;23:699–708. [PubMed]
6. Baerwald AR, Adams GP, Pierson RA. Ovarian antral folliculogenesis during the human menstrual cycle: a review. Hum Reprod Update. 2012;18:73–91. [PubMed]
7. Rajkovic A, Rangas S, Matzuk MM. Follicular development: mouse, sheep, and human models. In: Knobil E, Neill JD, editors. Knobil and Neill's physiology of reproduction. 3rd ed. New York: Elsvier; 2006. pp. 383–423.
8. Chun SY, Eisenhauer KM, Minami S, Billig H, Perlas E, Hsueh AJ. Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor. Endocrinology. 1996;137:1447–1456. [PubMed]
9. Dorrington JH, Moon YS, Armstrong DT. Estradiol-17beta biosynthesis in cultured granulosa cells from hypophysectomized immature rats; stimulation by follicle-stimulating hormone. Endocrinology. 1975;97:1328–1331. [PubMed]
10. Matzuk MM, Finegold MJ, Su JG, Hsueh AJ, Bradley A. Alpha-inhibin is a tumour-suppressor gene with gonadal specificity in mice. Nature. 1992;360:313–319. [PubMed]
11. Albertini DF, Combelles CM, Benecchi E, Carabatsos MJ. Cellular basis for paracrine regulation of ovarian follicle development. Reproduction. 2001;121:647–653. [PubMed]
12. Sato E, Kimura N, Yokoo M, Miyake Y, Ikeda JE. Morphodynamics of ovarian follicles during oogenesis in mice. Microsc Res Tech. 2006;69:427–435. [PubMed]
13. Varani S, Elvin JA, Yan C, DeMayo J, DeMayo FJ, Horton HF, et al. Knockout of pentraxin 3, a downstream target of growth differentiation factor-9, causes female subfertility. Mol Endocrinol. 2002;16:1154–1167. [PubMed]
14. Fulop C, Szanto S, Mukhopadhyay D, Bardos T, Kamath RV, Rugg MS, et al. Impaired cumulus mucification and female sterility in tumor necrosis factor-induced protein-6 deficient mice. Development. 2003;130:2253–2261. [PubMed]
15. Thomas FH, Ethier JF, Shimasaki S, Vanderhyden BC. Follicle-stimulating hormone regulates oocyte growth by modulation of expression of oocyte and granulosa cell factors. Endocrinology. 2005;146:941–949. [PubMed]
16. Kumar TR, Wang Y, Lu N, Matzuk MM. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet. 1997;15:201–204. [PubMed]
17. Matzuk MM. Revelations of ovarian follicle biology from gene knockout mice. Mol Cell Endocrinol. 2000;163:61–66. [PubMed]
18. Kumar TR, Low MJ, Matzuk MM. Genetic rescue of follicle-stimulating hormone beta-deficient mice. Endocrinology. 1998;139:3289–3295. [PubMed]
19. Yang Y, Balla A, Danilovich N, Sairam MR. Developmental and molecular aberrations associated with deterioration of oogenesis during complete or partial follicle-stimulating hormone receptor deficiency in mice. Biol Reprod. 2003;69:1294–1302. [PubMed]
20. Burns KH, Yan C, Kumar TR, Matzuk MM. Analysis of ovarian gene expression in follicle-stimulating hormone beta knockout mice. Endocrinology. 2001;142:2742–2751. [PubMed]
21. Baker J, Hardy MP, Zhou J, Bondy C, Lupu F, Bellve AR, et al. Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol. 1996;10:903–918. [PubMed]
22. Zhou J, Kumar TR, Matzuk MM, Bondy C. Insulin-like growth factor I regulates gonadotropin responsiveness in the murine ovary. Mol Endocrinol. 1997;11:1924–1933. [PubMed]
23. Layman LC. Mutations in the follicle-stimulating hormone-beta (FSH beta) and FSH receptor genes in mice and humans. Semin Reprod Med. 2000;18:5–10. [PubMed]
24. Touraine P, Beau I, Gougeon A, Meduri G, Desroches A, Pichard C, et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol Endocrinol. 1999;13:1844–1854. [PubMed]
25. Aguirre C, Jayes FC, Veldhuis JD. Luteinizing hormone (LH) drives diverse intracellular calcium second messenger signals in isolated porcine ovarian thecal cells: preferential recruitment of intracellular Ca2+ oscillatory cells by higher concentrations of LH. Endocrinology. 2000;141:2220–2228. [PubMed]
26. Filicori M, Cognigni GE, Samara A, Melappioni S, Perri T, Cantelli B, et al. The use of LH activity to drive folliculogenesis: exploring uncharted territories in ovulation induction. Hum Reprod Update. 2002;8:543–557. [PubMed]
27. Kumar TR. Functional analysis of LHbeta knockout mice. Mol Cell Endocrinol. 2007;269:81–84. [PubMed]
28. Zhang FP, Poutanen M, Wilbertz J, Huhtaniemi I. Normal prenatal but arrested postnatal sexual development of luteinizing hormone receptor knockout (LuRKO) mice. Mol Endocrinol. 2001;15:172–183. [PubMed]
29. Medigović I, Ristić N, Trifunović S, Manojlović-Stojanoski M, Milošević V, Zikić D, et al. Genistein affects ovarian folliculogenesis: A stereological study. Microsc Res Tech. 2012 Aug 28; [Epub]. http://dx.doi.org/10.1002/jemt.22117. [PubMed]
30. Korach KS, Emmen JM, Walker VR, Hewitt SC, Yates M, Hall JM, et al. Update on animal models developed for analyses of estrogen receptor biological activity. J Steroid Biochem Mol Biol. 2003;86:387–391. [PubMed]
31. Lee S, Kang DW, Hudgins-Spivey S, Krust A, Lee EY, Koo Y, et al. Theca-specific estrogen receptor-alpha knockout mice lose fertility prematurely. Endocrinology. 2009;150:3855–3862. [PubMed]
32. Dupont S, Krust A, Gansmuller A, Dierich A, Chambon P, Mark M. Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. Development. 2000;127:4277–4291. [PubMed]
33. Fisher CR, Graves KH, Parlow AF, Simpson ER. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proc Natl Acad Sci U S A. 1998;95:6965–6970. [PubMed]
34. Ito Y, Fisher CR, Conte FA, Grumbach MM, Simpson ER. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci U S A. 1993;90:11673–11677. [PubMed]
35. Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab. 1991;72:560–566. [PubMed]
36. Sharara FI, Nieman LK. Identification and cellular localization of growth hormone receptor gene expression in the human ovary. J Clin Endocrinol Metab. 1994;79:670–672. [PubMed]
37. Zaczek D, Hammond J, Suen L, Wandji S, Service D, Bartke A, et al. Impact of growth hormone resistance on female reproductive function: new insights from growth hormone receptor knockout mice. Biol Reprod. 2002;67:1115–1124. [PubMed]
38. Ryan NK, Woodhouse CM, Van der Hoek KH, Gilchrist RB, Armstrong DT, Norman RJ. Expression of leptin and its receptor in the murine ovary: possible role in the regulation of oocyte maturation. Biol Reprod. 2002;66:1548–1554. [PubMed]
39. Chehab FF, Lim ME, Lu R. Correction of the sterility defect in homozygous obese female mice by treatment with the human recombinant leptin. Nat Genet. 1996;12:318–320. [PubMed]
40. Barkan D, Jia H, Dantes A, Vardimon L, Amsterdam A, Rubinstein M. Leptin modulates the glucocorticoid-induced ovarian steroidogenesis. Endocrinology. 1999;140:1731–1738. [PubMed]
41. Zachow RJ, Magoffin DA. Direct intraovarian effects of leptin: impairment of the synergistic action of insulin-like growth factor-I on follicle-stimulating hormone-dependent estradiol-17 beta production by rat ovarian granulosa cells. Endocrinology. 1997;138:847–850. [PubMed]
42. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, et al. Biological action of leptin as an angiogenic factor. Science. 1998;281:1683–1686. [PubMed]
43. Findlay JK. An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod. 1993;48:15–23. [PubMed]
44. Hillier SG, Yong EL, Illingworth PJ, Baird DT, Schwall RH, Mason AJ. Effect of recombinant activin on androgen synthesis in cultured human thecal cells. J Clin Endocrinol Metab. 1991;72:1206–1211. [PubMed]
45. Matzuk MM, Kumar TR, Bradley A. Different phenotypes for mice deficient in either activins or activin receptor type II. Nature. 1995;374:356–360. [PubMed]
46. Matzuk MM, Finegold MJ, Mishina Y, Bradley A, Behringer RR. Synergistic effects of inhibins and mullerian-inhibiting substance on testicular tumorigenesis. Mol Endocrinol. 1995;9:1337–1345. [PubMed]
47. Campbell BK, Baird DT. Inhibin A is a follicle stimulating hormone-responsive marker of granulosa cell differentiation, which has both autocrine and paracrine actions in sheep. J Endocrinol. 2001;169:333–345. [PubMed]
48. Knight PG, Glister C. TGF-beta superfamily members and ovarian follicle development. Reproduction. 2006;132:191–206. [PubMed]
49. Schneyer AL, Fujiwara T, Fox J, Welt CK, Adams J, Messerlian GM, et al. Dynamic changes in the intrafollicular inhibin/activin/follistatin axis during human follicular development: relationship to circulating hormone concentrations. J Clin Endocrinol Metab. 2000;85:3319–3330. [PubMed]
50. Schwall RH, Mason AJ, Wilcox JN, Bassett SG, Zeleznik AJ. Localization of inhibin/activin subunit mRNAs within the primate ovary. Mol Endocrinol. 1990;4:75–79. [PubMed]
51. Arai KY, Kishi H, Onodera S, Jin W, Watanabe G, Suzuki AK, et al. Cyclic changes in messenger RNAs encoding inhibin/activin subunits in the ovary of the golden hamster (Mesocricetus auratus) J Endocrinol. 2005;185:561–575. [PubMed]
52. Alak BM, Coskun S, Friedman CI, Kennard EA, Kim MH, Seifer DB. Activin A stimulates meiotic maturation of human oocytes and modulates granulosa cell steroidogenesis in vitro. Fertil Steril. 1998;70:1126–1130. [PubMed]
53. Sadatsuki M, Tsutsumi O, Yamada R, Muramatsu M, Taketani Y. Local regulatory effects of activin A and follistatin on meiotic maturation of rat oocytes. Biochem Biophys Res Commun. 1993;196:388–395. [PubMed]
54. Silva CC, Knight PG. Modulatory actions of activin-A and follistatin on the developmental competence of in vitro-matured bovine oocytes. Biol Reprod. 1998;58:558–565. [PubMed]
55. Durlinger AL, Visser JA, Themmen AP. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction. 2002;124:601–609. [PubMed]
56. Sirotkin AV. Growth factors controlling ovarian functions. J Cell Physiol. 2011;226:2222–2225. [PubMed]
57. Wandji SA, Wood TL, Crawford J, Levison SW, Hammond JM. Expression of mouse ovarian insulin growth factor system components during follicular development and atresia. Endocrinology. 1998;139:5205–5214. [PubMed]
58. Zhou Y, Kato H, Asanoma K, Kondo H, Arima T, Kato K, et al. Identification of FOXC1 as a TGF-beta1 responsive gene and its involvement in negative regulation of cell growth. Genomics. 2002;80:465–472. [PubMed]
59. Mattiske D, Kume T, Hogan BL. The mouse forkhead gene Foxc1 is required for primordial germ cell migration and antral follicle development. Dev Biol. 2006;290:447–458. [PubMed]
60. Juneja SC, Barr KJ, Enders GC, Kidder GM. Defects in the germ line and gonads of mice lacking connexin43. Biol Reprod. 1999;60:1263–1270. [PubMed]
61. Kidder GM, Mhawi AA. Gap junctions and ovarian folliculogenesis. Reproduction. 2002;123:613–620. [PubMed]
62. Simon AM, Goodenough DA, Li E, Paul DL. Female infertility in mice lacking connexin 37. Nature. 1997;385:525–529. [PubMed]
63. Otsuka F, Moore RK, Shimasaki S. Biological function and cellular mechanism of bone morphogenetic protein-6 in the ovary. J Biol Chem. 2001;276:32889–32895. [PubMed]
64. Wrathall JH, Knight PG. Effects of inhibin-related peptides and oestradiol on androstenedione and progesterone secretion by bovine theca cells in vitro. J Endocrinol. 1995;145:491–500. [PubMed]
65. Souza CJ, Campbell BK, McNeilly AS, Baird DT. Effect of bone morphogenetic protein 2 (BMP2) on oestradiol and inhibin A production by sheep granulosa cells, and localization of BMP receptors in the ovary by immunohistochemistry. Reproduction. 2002;123:363–369. [PubMed]
66. Otsuka F. Multiple endocrine regulation by bone morphogenetic protein system. Endocr J. 2010;57:3–14. [PubMed]
67. Erickson GF, Shimasaki S. The role of the oocyte in folliculogenesis. Trends Endocrinol Metab. 2000;11:193–198. [PubMed]
68. Lee WS, Otsuka F, Moore RK, Shimasaki S. Effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol Reprod. 2001;65:994–999. [PubMed]
69. Pierre A, Pisselet C, Dupont J, Mandon-Pepin B, Monniaux D, Monget P, et al. Molecular basis of bone morphogenetic protein-4 inhibitory action on progesterone secretion by ovine granulosa cells. J Mol Endocrinol. 2004;33:805–817. [PubMed]
70. Pierre A, Pisselet C, Dupont J, Bontoux M, Monget P. Bone morphogenetic protein 5 expression in the rat ovary: biological effects on granulosa cell proliferation and steroidogenesis. Biol Reprod. 2005;73:1102–1108. [PubMed]
71. Pangas SA, Jorgez CJ, Matzuk MM. Growth differentiation factor 9 regulates expression of the bone morphogenetic protein antagonist gremlin. J Biol Chem. 2004;279:32281–32286. [PubMed]
72. Nilsson EE, Doraiswamy V, Skinner MK. Transforming growth factor-beta isoform expression during bovine ovarian antral follicle development. Mol Reprod Dev. 2003;66:237–246. [PubMed]
73. Dunkel L, Tilly JL, Shikone T, Nishimori K, Hsueh AJ. Follicle-stimulating hormone receptor expression in the rat ovary: increases during prepubertal development and regulation by the opposing actions of transforming growth factors beta and alpha. Biol Reprod. 1994;50:940–948. [PubMed]
74. Drummond AE, Dyson M, Thean E, Groome NP, Robertson DM, Findlay JK. Temporal and hormonal regulation of inhibin protein and subunit mRNA expression by post-natal and immature rat ovaries. J Endocrinol. 2000;166:339–354. [PubMed]
75. Fournet N, Weitsman SR, Zachow RJ, Magoffin DA. Transforming growth factor-beta inhibits ovarian 17 alpha-hydroxylase activity by a direct noncompetitive mechanism. Endocrinology. 1996;137:166–174. [PubMed]
76. Uzumcu M, Pan Z, Chu Y, Kuhn PE, Zachow R. Immunolocalization of the hepatocyte growth factor (HGF) system in the rat ovary and the anti-apoptotic effect of HGF in rat ovarian granulosa cells in vitro. Reproduction. 2006;132:291–299. [PubMed]
77. Baker J, Hardy MP, Zhou J, Bondy C, Lupu F, Bellve AR, et al. Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol. 1996;10:903–918. [PubMed]
78. Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY, et al. Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature. 1996;384:470–474. [PubMed]
79. Duggavathi R, Murphy BD. Development. Ovulation signals. Science. 2009;324:890–891. [PubMed]
80. Ota T, Choi KB, Gilks CB, Leung PC, Auersperg N. Cell type- and stage-specific changes in HOXA7 protein expression in human ovarian folliculogenesis: possible role of GDF-9. Differentiation. 2006;74:1–10. [PubMed]
81. Sato E, Ishibashi T, Koide SS. Prevention of spontaneous degeneration of mouse oocytes in culture by ovarian glycosaminoglycans. Biol Reprod. 1987;37:371–376. [PubMed]
82. Wang H, Jiang JY, Zhu C, Peng C, Tsang BK. Role and regulation of nodal/activin receptor-like kinase 7 signaling pathway in the control of ovarian follicular atresia. Mol Endocrinol. 2006;20:2469–2482. [PubMed]
83. Matsumoto K, Nakayama T, Sakai H, Tanemura K, Osuga H, Sato E, et al. Neuronal apoptosis inhibitory protein (NAIP) may enhance the survival of granulosa cells thus indirectly affecting oocyte survival. Mol Reprod Dev. 1999;54:103–111. [PubMed]
84. Kezele P, Nilsson EE, Skinner MK. Keratinocyte growth factor acts as a mesenchymal factor that promotes ovarian primordial to primary follicle transition. Biol Reprod. 2005;73:967–973. [PubMed]
85. Parrott JA, Skinner MK. Thecal cell-granulosa cell interactions involve a positive feedback loop among keratinocyte growth factor, hepatocyte growth factor, and Kit ligand during ovarian follicular development. Endocrinology. 1998;139:2240–2245. [PubMed]
86. Eppig JJ, Wigglesworth K, Pendola FL. The mammalian oocyte orchestrates the rate of ovarian follicular development. Proc Natl Acad Sci U S A. 2002;99:2890–2894. [PubMed]
87. Eppig JJ. Oocyte control of ovarian follicular development and function in mammals. Reproduction. 2001;122:829–838. [PubMed]
88. Gilchrist RB, Ritter LJ, Armstrong DT. Oocyte-somatic cell interactions during follicle development in mammals. Anim Reprod Sci. 2004;82-83:431–446. [PubMed]
89. Erickson GF, Shimasaki S. The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle. Reprod Biol Endocrinol. 2003;1:9. [PMC free article] [PubMed]
90. Vitt UA, Hsueh AJ. Stage-dependent role of growth differentiation factor-9 in ovarian follicle development. Mol Cell Endocrinol. 2001;183:171–177. [PubMed]
91. Nilsson EE, Skinner MK. Growth and differentiation factor-9 stimulates progression of early primary but not primordial rat ovarian follicle development. Biol Reprod. 2002;67:1018–1024. [PubMed]
92. Vitt UA, Hayashi M, Klein C, Hsueh AJ. Growth differentiation factor-9 stimulates proliferation but suppresses the follicle-stimulating hormone-induced differentiation of cultured granulosa cells from small antral and preovulatory rat follicles. Biol Reprod. 2000;62:370–377. [PubMed]
93. Yamamoto N, Christenson LK, McAllister JM, Strauss JF., 3rd Growth differentiation factor-9 inhibits 3'5'-adenosine monophosphate-stimulated steroidogenesis in human granulosa and theca cells. J Clin Endocrinol Metab. 2002;87:2849–2856. [PubMed]
94. Elvin JA, Clark AT, Wang P, Wolfman NM, Matzuk MM. Paracrine actions of growth differentiation factor-9 in the mammalian ovary. Mol Endocrinol. 1999;13:1035–1048. [PubMed]
95. Glister C, Richards SL, Knight PG. Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling? Endocrinology. 2005;146:1883–1892. [PubMed]
96. Otsuka F, Moore RK, Iemura S, Ueno N, Shimasaki S. Follistatin inhibits the function of the oocyte-derived factor BMP-15. Biochem Biophys Res Commun. 2001;289:961–966. [PubMed]
97. Glister C, Kemp CF, Knight PG. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction. 2004;127:239–254. [PubMed]
98. Otsuka F, Yao Z, Lee T, Yamamoto S, Erickson GF, Shimasaki S. Bone morphogenetic protein-15. Identification of target cells and biological functions. J Biol Chem. 2000;275:39523–39528. [PubMed]
99. Di Pasquale E, Beck-Peccoz P, Persani L. Hypergonadotropic ovarian failure associated with an inherited mutation of human bone morphogenetic protein-15 (BMP15) gene. Am J Hum Genet. 2004;75:106–111. [PubMed]
100. Moore RK, Otsuka F, Shimasaki S. Molecular basis of bone morphogenetic protein-15 signaling in granulosa cells. J Biol Chem. 2003;278:304–310. [PubMed]
101. Yi SE, LaPolt PS, Yoon BS, Chen JY, Lu JK, Lyons KM. The type I BMP receptor BmprIB is essential for female reproductive function. Proc Natl Acad Sci U S A. 2001;98:7994–7999. [PubMed]
102. Chang CL, Wang HS, Soong YK, Huang SY, Pai SY, Hsu SY. Regulation of oocyte and cumulus cell interactions by intermedin/adrenomedullin 2. J Biol Chem. 2011;286:43193–43203. [PMC free article] [PubMed]
103. Ackert CL, Gittens JE, O'Brien MJ, Eppig JJ, Kidder GM. Intercellular communication via connexin43 gap junctions is required for ovarian folliculogenesis in the mouse. Dev Biol. 2001;233:258–270. [PubMed]
104. Burghardt RC, Matheson RL. Gap junction amplification in rat ovarian granulosa cells. I. A direct response to follicle-stimulating hormone. Dev Biol. 1982;94:206–215. [PubMed]
105. Granot I, Dekel N. Developmental expression and regulation of the gap junction protein and transcript in rat ovaries. Mol Reprod Dev. 1997;47:231–239. [PubMed]
106. Sommersberg B, Bulling A, Salzer U, Frohlich U, Garfield RE, Amsterdam A, et al. Gap junction communication and connexin 43 gene expression in a rat granulosa cell line: regulation by follicle-stimulating hormone. Biol Reprod. 2000;63:1661–1668. [PubMed]
107. Granot I, Dekel N. Phosphorylation and expression of connexin-43 ovarian gap junction protein are regulated by luteinizing hormone. J Biol Chem. 1994;269:30502–30509. [PubMed]
108. Granot I, Bechor E, Barash A, Dekel N. Connexin43 in rat oocytes: developmental modulation of its phosphorylation. Biol Reprod. 2002;66:568–573. [PubMed]
109. Grøndahl ML, Andersen CY, Bogstad J, Borgbo T, Boujida VH, Borup R. Specific genes are selectively expressed between cumulus and granulosa cells from individual human pre-ovulatory follicles. Mol Hum Reprod. 2012 Aug 24; [Epub]. http://dx.doi.org/10.1093/molehr/gas035. [PubMed]
110. Eppig JJ, Schroeder AC. Capacity of mouse oocytes from preantral follicles to undergo embryogenesis and development to live young after growth, maturation, and fertilization in vitro. Biol Reprod. 1989;41:268–276. [PubMed]
111. Eppig JJ, O'Brien MJ. Development in vitro of mouse oocytes from primordial follicles. Biol Reprod. 1996;54:197–207. [PubMed]
112. Hovatta O, Silye R, Abir R, Krausz T, Winston RM. Extracellular matrix improves survival of both stored and fresh human primordial and primary ovarian follicles in long-term culture. Hum Reprod. 1997;12:1032–1036. [PubMed]
113. Oktem O, Oktay K. The role of extracellular matrix and activin-A in in vitro growth and survival of murine preantral follicles. Reprod Sci. 2007;14:358–366. [PubMed]
114. Desai N, Abdelhafez F, Calabro A, Falcone T. Three dimensional culture of fresh and vitrified mouse pre-antral follicles in a hyaluronan-based hydrogel: a preliminary investigation of a novel biomaterial for in vitro follicle maturation. Reprod Biol Endocrinol. 2012;10:29. [PMC free article] [PubMed]
115. Nation A, Selwood L. The production of mature oocytes from adult ovaries following primary follicle culture in a marsupial. Reproduction. 2009;138:247–255. [PubMed]
116. Mousset-Simeon N, Jouannet P, Le Cointre L, Coussieu C, Poirot C. Comparison of three in vitro culture systems for maturation of early preantral mouse ovarian follicles. Zygote. 2005;13:167–175. [PubMed]
117. Kreeger PK, Deck JW, Woodruff TK, Shea LD. The in vitro regulation of ovarian follicle development using alginate-extracellular matrix gels. Biomaterials. 2006;27:714–723. [PMC free article] [PubMed]
118. Lee S. Role of estrogen receptor alpha (ERα) in the folliculogenesis [dissertation] Seoul (KR): Sungshin Women's University; 2010.
119. Visser JA, Themmen AP. Anti-Mullerian hormone and folliculogenesis. Mol Cell Endocrinol. 2005;234:81–86. [PubMed]
120. Faddy MJ, Gosden RG. A mathematical model of follicle dynamics in the human ovary. Hum Reprod. 1995;10:770–775. [PubMed]
121. Faddy MJ, Gosden RG. A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod. 1996;11:1484–1486. [PubMed]

Articles from Clinical and Experimental Reproductive Medicine are provided here courtesy of Korean Society for Reproductive Medicine